###begin article-title 0
Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1
###end article-title 0
###begin p 1
###xml 39 63 39 63 <email xmlns:xlink="http://www.w3.org/1999/xlink">sonia.najjar@utoledo.edu</email>
Corresponding author: Sonia M. Najjar, sonia.najjar@utoledo.edu
###end p 1
###begin p 2
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See  for details.
###end p 2
###begin p 3
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OBJECTIVE&#8212;</bold>
###xml 143 144 143 144 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 474 477 474 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 477 480 477 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
###xml 429 433 <span type="species:ncbi:10090">mice</span>
OBJECTIVE-Liver-specific inactivation of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) by a dominant-negative transgene (l-SACC1 mice) impaired insulin clearance, caused insulin resistance, and increased hepatic lipogenesis. To discern whether this phenotype reflects a physiological function of CEACAM1 rather than the effect of the dominant-negative transgene, we characterized the metabolic phenotype of mice with null mutation of the Ceacam1 gene (Cc1-/-).
###end p 3
###begin p 4
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESEARCH DESIGN AND METHODS&#8212;</bold>
###xml 200 203 200 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 203 206 203 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 221 224 221 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 224 227 224 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 28 32 <span type="species:ncbi:10090">Mice</span>
###xml 180 184 <span type="species:ncbi:10090">mice</span>
RESEARCH DESIGN AND METHODS-Mice were originally generated on a mixed C57BL/6x129sv genetic background and then backcrossed 12 times onto the C57BL/6 background. More than 70 male mice of each of the Cc1-/- and wild-type Cc1+/+ groups were subjected to metabolic analyses, including insulin tolerance, hyperinsulinemic-euglycemic clamp studies, insulin secretion in response to glucose, and determination of fasting serum insulin, C-peptide, triglyceride, and free fatty acid levels.
###end p 4
###begin p 5
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESULTS&#8212;</bold>
###xml 13 14 13 14 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 22 25 22 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 25 28 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 381 384 381 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 384 387 384 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 596 599 593 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 599 602 596 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
###xml 388 392 <span type="species:ncbi:10090">mice</span>
###xml 603 607 <span type="species:ncbi:10090">mice</span>
RESULTS-Like l-SACC1, Cc1-/- mice exhibited impairment of insulin clearance and hyperinsulinemia, which caused insulin resistance beginning at 2 months of age, when the mutation was maintained on a mixed C57BL/6x129sv background, but not until 5-6 months of age on a homogeneous inbred C57BL/6 genetic background. Hyperinsulinemic-euglycemic clamp studies revealed that the inbred Cc1-/- mice developed insulin resistance primarily in liver. Despite substantial expression of CEACAM1 in pancreatic beta-cells, insulin secretion in response to glucose in vivo and in isolated islets was normal in Cc1-/- mice (inbred and outbred strains).
###end p 5
###begin p 6
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CONCLUSIONS&#8212;</bold>
###xml 99 100 99 100 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 111 114 111 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 114 117 114 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
CONCLUSIONS-Intact insulin secretion in response to glucose and impairment of insulin clearance in l-SACC1 and Cc1-/- mice suggest that the principal role of CEACAM1 in insulin action is to mediate insulin clearance in liver.
###end p 6
###begin p 7
Published ahead of print at  on 10 June 2008.
###end p 7
###begin p 8
A.M.D. and G.H. contributed equally to this work. T.A.B. and P.R.P. contributed equally to this work.
###end p 8
###begin p 9
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 9
###begin p 10
###xml 576 577 561 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 578 579 563 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
In response to physiological stimuli, insulin is secreted from pancreatic beta-cells into the portal circulation in a pulsatile manner. Through its first passage, approximately50% of the secreted insulin is cleared in liver. Insulin clearance is a critical regulator of insulin action. Impaired insulin clearance is seen in response to peripheral insulin resistance. On the other hand, impaired insulin clearance can be the primary cause of insulin resistance by causing downregulation of insulin receptors and hepatic lipogenesis, both of which result in insulin resistance (1-3).
###end p 10
###begin p 11
###xml 105 106 105 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 107 108 107 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 345 346 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 347 348 347 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 612 613 612 613 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 626 627 626 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 628 630 628 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 779 780 779 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 620 624 <span type="species:ncbi:10090">mice</span>
Insulin clearance in liver is mediated by receptor-mediated insulin endocytosis followed by degradation (1,4). Upon its phosphorylation by the insulin receptor, the carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) takes part of the insulin-receptor endocytosis complex to promote insulin uptake and removal in the hepatocyte (5-7). Moreover, liver-specific overexpression of a dominant-negative S503A phosphorylation-defective isoform of CEACAM1 impairs insulin clearance and causes chronic hyperinsulinemia and insulin resistance, together with increased visceral obesity and dyslipidemia in l-SACC1 mice (8-10). In agreement with this finding, activation of SHP-1, a CEACAM1 phosphatase, adversely affects glucose homeostasis by impairing insulin clearance (9). These data suggest that CEACAM1 regulates insulin action by promoting hepatic insulin clearance.
###end p 11
###begin p 12
###xml 116 119 116 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 119 122 119 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
To further investigate its function in insulin action in vivo, we have characterized the metabolic phenotype of the Cc1-/- mice homozygous for null mutation of the Ceacam1 gene. We report here that, similar to liver-specific inactivation of CEACAM1, its null mutation causes impaired insulin clearance, hyperinsulinemia, hepatic steatosis, and visceral adiposity. Moreover, the phenotype is associated with hepatic insulin resistance, which is evident at an earlier age, when the mutation is propagated on a mixed C57BL/6x129sv compared with a homogenous C57BL/6 genetic background. These data suggest that the principal role of CEACAM1 is to promote insulin clearance in liver.
###end p 12
###begin title 13
RESEARCH DESIGN AND METHODS
###end title 13
###begin title 14
Animal husbandry.
###end title 14
###begin p 15
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
Cc1-/--null mice were generated on a mixed C57BL/6x129sv background and backcrossed 12 times onto the C57BL/6 background (11). Animals were kept in a 12-h dark/light cycle and fed standard chow ad libitum. All procedures were approved by the Institutional Animal Care and Utilization Committee. Male mice from 2 to 10 months of age were studied.
###end p 15
###begin title 16
Metabolic analysis.
###end title 16
###begin p 17
###xml 63 67 <span type="species:ncbi:10090">mice</span>
After an overnight fast (from 1700 until 1100 h the next day), mice were anesthetized with sodium pentobarbital (55 mg/kg body wt), and whole venous blood was drawn from retroorbital sinuses to measure fasting glucose levels using a glucometer (Accu-chek Aviva; Roche), serum insulin and C-peptide levels by radioimmunoassays (Linco), serum FFAs by NEFA C kit (Wako), and serum triglycerides (Pointe Scientific). Serum total bilirubin and cholesterol were measured using a bilirubin calibrator and Infinity Cholesterol reagent (Sigma), respectively, and blood uric acid was measured using Infinity BUN reagent (Sigma). Visceral adiposity was expressed as percentage weight of white adipose tissue per total body weight.
###end p 17
###begin title 18
Hyperinsulinemic-euglycemic clamps to assess insulin action in vivo.
###end title 18
###begin p 19
###xml 94 95 94 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 234 236 222 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 242 244 230 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 298 300 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 408 409 396 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 579 581 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 601 603 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 178 183 <span type="species:ncbi:9606">human</span>
After an overnight fast, a 2-h hyperinsulinemic-euglycemic clamp was conducted in awake mice (n = 11approximately12) with a primed (150 mU/kg body wt) and continuous infusion of human regular insulin (Humulin) at a rate of 2.5 mU . kg-1 . min-1 to raise serum insulin within a physiological range (10). Basal and insulin-stimulated whole-body glucose turnover were estimated with a continuous infusion of [3-3H]glucose (PerkinElmer Life and Analytical Sciences) for 2 h before (0.05 muCi/min) and throughout the clamps (0.1 muCi/min). Tissues were removed to determine glycogen (10) and triglyceride (12) content.
###end p 19
###begin title 20
Insulin tolerance test.
###end title 20
###begin p 21
###xml 58 62 <span type="species:ncbi:10090">mice</span>
After an overnight fast (1700 until 1100 h the next day), mice were anesthetized and injected intraperitoneally with 0.125 units insulin/kg body wt, and their venous blood from the retroorbital sinuses was drawn at 0-5 h after injection to determine blood glucose levels.
###end p 21
###begin title 22
Intraperitoneal glucose tolerance test and acute insulin secretion.
###end title 22
###begin p 23
###xml 71 75 <span type="species:ncbi:10090">mice</span>
After an overnight fast (1700 until 0800 h the next day), anesthetized mice were injected intraperitoneally with glucose (2.0 g/kg body wt), and their venous blood was drawn at 0-30 min after injection to determine blood glucose and serum insulin levels.
###end p 23
###begin title 24
Glucose-6-phosphate content.
###end title 24
###begin p 25
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
Liver was removed from randomly fed mice and snap-frozen, and glucose-6-phosphate (G6P) content was determined in 1-g tissue homogenates using G6P dehydrogenase (12). Absorbance was measured at 340 nm before and after addition of enzyme.
###end p 25
###begin title 26
Cell culture.
###end title 26
###begin p 27
###xml 24 26 20 22 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 50 52 43 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 93 94 80 81 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 154 160 <span type="species:ncbi:9913">bovine</span>
Murine alpha-TC6 cells (13) and Min-6 beta-cells (14) were maintained at 37degreesC and 5% CO2 in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum and penicillin and streptomycin. All experiments were performed on 80% confluent cells.
###end p 27
###begin title 28
Western blot.
###end title 28
###begin p 29
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 515 526 <span type="species:ncbi:3704">horseradish</span>
###xml 554 558 <span type="species:ncbi:9925">goat</span>
###xml 596 601 <span type="species:ncbi:10090">mouse</span>
###xml 627 633 <span type="species:ncbi:9986">rabbit</span>
The concentration of proteins in tissue and serum lysates was quantitated by BCA protein assay (Pierce) before analysis by 7 or 4-12% gradient SDS-PAGE (Invitrogen), respectively, and immunoprobing with specific antibodies. These included polyclonal antibodies against ApoB48/100 (Chemicon International), fatty acid synthase (FAS) (15), and fatty acid transporter-1 (FATP-1) (I-20; Santa Cruz Biotechnology) in addition to monoclonal antibodies against actin (Sigma) and tubulin (Sigma). Blots were incubated with horseradish peroxidase-conjugated anti-goat IgG (Santa Cruz Biotechnology), anti-mouse IgG (Amersham), and anti-rabbit IgG (Amersham) antibodies, and proteins were detected by enhanced chemiluminescence (Amersham) and quantified by densitometry.
###end p 29
###begin p 30
###xml 182 184 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 121 126 <span type="species:ncbi:10090">mouse</span>
Pancreatic cells were lysed, and 1 mg protein was subjected to immunoprecipitation, as previously described with an anti-mouse polyclonal antibody against BGP1 (alpha-mCC1; Ab-231) (16) and analysis on SDS-PAGE, followed by immunoprobing with Ab-231 to normalize for the amount of CEACAM1 in the immunopellet.
###end p 30
###begin p 31
###xml 221 225 213 214 <sub xmlns:xlink="http://www.w3.org/1999/xlink">&#946;</sub>
###xml 397 401 374 375 <sub xmlns:xlink="http://www.w3.org/1999/xlink">&#946;</sub>
For phosphorylation experiments, livers were removed, and 200 mug lysates was treated with 100 nmol/l insulin for 5 min before immunoprecipitation with antibodies against the beta-subunit of the insulin receptor (alpha-IRbeta) (Santa Cruz Biotechnology) followed by SDS-PAGE analysis and immunoblotting with alpha-phosphotyrosine antibody (alpha-pTyr) (Upstate Biotechnology), followed by alpha-IRbeta to normalize against the amount of insulin receptor in the immunopellet.
###end p 31
###begin title 32
Northern blot.
###end title 32
###begin p 33
Liver mRNA was purified using TRIzol (Invitrogen) followed by the MicroPoly (A) Pure kit (Ambion) and analysis by probing with cDNAs for glucose-6-phosphatase (G6Pase), carnitine palmitoyl transferase 1 (CPT1), PEPCK, pyruvate dehydrogenate kinase (PDK-4), glucokinase, and sterol regulatory element-binding protein 1c (SREBP-1c), using the Random Primed DNA Labeling kit (Roche) before reprobing with beta-actin cDNA to normalize against the amount of mRNA applied.
###end p 33
###begin title 34
Insulin secretion from isolated islets.
###end title 34
###begin p 35
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 142 146 <span type="species:ncbi:9913">calf</span>
Islets were purified from pancreata of 6-month-old mice by collagenase digestion (17). Islets were resuspended in RPMI containing 10% newborn calf serum and 5.5 mmol/l glucose and cultured overnight at 37degreesC. Islets were stimulated with glucose (2.8-16.8 mmol/l) or 20 mmol/l KCl for 1 h at 37degreesC and collected by centrifugation, and the supernatant was assayed for insulin content by radioimmunoassay. Islets were dissolved in high-salt buffer and sonicated three times at 80 watts for 10 s, and DNA concentration was determined to normalize insulin content.
###end p 35
###begin title 36
Fluorescence-activated cell sorter purification of isolated islets.
###end title 36
###begin p 37
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 236 238 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
Islets were isolated by the intraductal collagenase digestion method (18). After PBS wash, the suspension was passed through a 35-mum filter before fluorescence-activated cell sorter (FACS) analysis, based on autofluorescence and size (19). Cells were sorted directly into TRIzol reagent, and the purity of the sorted fractions was determined by real-time PCR for insulin and glucagon in each fraction.
###end p 37
###begin title 38
beta-Cell area and immunohistochemistry.
###end title 38
###begin p 39
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 177 187 <span type="species:ncbi:10141">guinea pig</span>
###xml 193 198 <span type="species:ncbi:9606">human</span>
###xml 244 250 <span type="species:ncbi:9793">donkey</span>
###xml 256 266 <span type="species:ncbi:10141">guinea pig</span>
###xml 319 324 <span type="species:ncbi:10090">mouse</span>
###xml 388 394 <span type="species:ncbi:9793">donkey</span>
###xml 400 405 <span type="species:ncbi:10090">mouse</span>
###xml 476 482 <span type="species:ncbi:9986">rabbit</span>
###xml 530 536 <span type="species:ncbi:9793">donkey</span>
###xml 542 548 <span type="species:ncbi:9986">rabbit</span>
Mice were anesthetized, and pancreata were dissected, weighed, fixed in Bouin's solution, sectioned, and stained (20). Antibodies used for the immunofluorescence staining were: guinea pig anti-human insulin (Linco Research) and AMCA-conjugated donkey anti-guinea pig antibody (Jackson Immunoresearch) for insulin; anti-mouse glucagons monoclonal antibody (Sigma) and Texas red-conjugated donkey anti-mouse antibody (Jackson Immunoresearch) for glucagon; and anti-somatostatin rabbit polyclonal antibody (Abcam) and Cy2-conjugated donkey anti-rabbit antibody (Jackson Immunoresearch) for somatostatin. beta-Cell area was calculated by morphometric analysis using Image J software (National Institutes of Health; ), and the insulin-stained area was divided by total pancreas area.
###end p 39
###begin title 40
Real-time PCR.
###end title 40
###begin p 41
RNA was extracted using TRIzol method according to the manufacturer's protocol. After DNAse digestion (DNAfree; Ambion), 100 ng RNA was transcribed into cDNA in a 20-mul reaction using a High Capacity cDNA Archive kit (Applied Biosystems), analyzed, and amplified (ABI 7900 HT system). PCR was performed in a 10-mul reaction, containing 5 mul cDNA (one-fifth diluted), 1xSYBR Green PCR Master Mix (Applied Biosystems), and 300 nmol/l of each primer: Ceacam1 forward primer, AATCTGCCCCTGGCGCTTGGAGCC; Ceacam1 reverse primer, AAATCGCACAGTCGCCTGAGTACG; beta-actin forward primer, AGGGCTATGCTCTCCCTCAC; and beta-actin reverse primer, AAGGAAGGCTGGAAAAGAGC.
###end p 41
###begin p 42
Cycle threshold (Ct) values were used to calculate the amount of amplified PCR product relative to beta-actin. The relative amount of mRNA was calculated as 2-DeltaCT. Results are expressed in fold change as means +/- SE.
###end p 42
###begin title 43
Statistical analysis.
###end title 43
###begin p 44
###xml 83 84 83 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 91 92 91 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Data were analyzed with SPSS software using one-factor ANOVA analysis or Student's t test. P < 0.05 was statistically significant.
###end p 44
###begin title 45
RESULTS
###end title 45
###begin title 46
###xml 38 41 38 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 41 44 41 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Body weight and composition in inbred Cc1-/- mice.
###end title 46
###begin p 47
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 120 123 120 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 123 126 123 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 171 178 171 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 238 239 238 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1</sup>
###xml 274 281 274 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 400 407 400 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
Cc1-/- mice on inbred C57BL/6 genetic background exhibit an increase in body weight in comparison with their wild-type (Cc1+/+) counterparts, starting at 2 months of age (Table 1). Parallel increase in whole-body fat mass, as assessed by 1H-magnetic resonance spectrometry (Table 1), is attributed to increased visceral adiposity, as measured by % visceral fat per body weight, but not to lean mass (Table 1).
###end p 47
###begin title 48
###xml 58 61 58 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 61 64 61 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
Hyperinsulinemia and impaired insulin clearance in inbred Cc1-/- mice.
###end title 48
###begin p 49
###xml 115 118 113 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 118 121 116 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 149 152 145 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 152 155 148 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 162 163 158 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 217 220 211 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 220 223 214 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 251 254 243 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 254 257 246 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 264 265 256 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 389 392 377 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 392 395 380 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 402 403 390 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 426 429 414 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 429 432 417 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
###xml 258 262 <span type="species:ncbi:10090">mice</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
Null mutation of Ceacam1 does not alter liver function, as indicated by normal serum cholesterol (77.5 +/- 5.30 in Cc1-/- vs. 86.0 +/- 3.74 mg/dl in Cc1+/+ mice; P > 0.05) and total bilirubin levels (0.29 +/- 0.02 in Cc1-/- vs. 0.27 +/- 0.02 mg/dl in Cc1+/+ mice; P > 0.05). Similarly, kidney function, as assessed by normal serum uric acid level (1.38 +/- 0.15 vs. 1.24 +/- 0.11 mg/dl in Cc1+/+ mice; P > 0.05), is intact in Cc1-/- mice.
###end p 49
###begin p 50
###xml 7 10 7 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 10 13 10 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 139 146 127 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 300 303 276 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 303 306 279 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 319 322 295 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 322 325 298 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 332 339 308 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 395 398 371 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 398 401 374 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 474 477 450 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 477 480 453 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 532 538 508 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1</xref>
###xml 560 563 536 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 563 566 539 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
###xml 402 406 <span type="species:ncbi:10090">mice</span>
###xml 567 571 <span type="species:ncbi:10090">mice</span>
Inbred Cc1-/- mice exhibit a slight increase (approximately1.5- to 2.0-fold) in fasting serum insulin levels, starting at 2 months of age (Table 1). Insulin clearance, measured by steady-state C-peptide-to-insulin molar ratio, is significantly reduced (by approximately1.5-fold) in 2- to 6-month-old Cc1-/- relative to Cc1+/+ mice (Table 1). Furthermore, insulin injection in 2- and 6-month-old Cc1-/- mice results in a prolonged suppression of blood glucose, as opposed to Cc1+/+, in which glucose levels return to basal in 3-4 h (Fig. 1). This suggests that Cc1-/- mice clear exogenous insulin less efficiently. Taken together, the data propose that null mutation of Ceacam1 causes hyperinsulinemia and impairs insulin clearance.
###end p 50
###begin title 51
###xml 45 48 45 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 48 51 48 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Secondary insulin resistance in older inbred Cc1-/- mice.
###end title 51
###begin p 52
###xml 113 116 113 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 116 119 116 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 163 165 159 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 171 173 167 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 177 180 173 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 180 183 176 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 190 191 186 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 376 379 368 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 379 382 371 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 389 390 381 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 551 553 527 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 559 561 535 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 565 568 541 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 568 571 544 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 578 579 554 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 184 188 <span type="species:ncbi:10090">mice</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
###xml 507 511 <span type="species:ncbi:10090">mice</span>
###xml 572 576 <span type="species:ncbi:10090">mice</span>
The steady-state glucose infusion rate required to maintain euglycemia during the clamp is normal in 3-month-old Cc1-/- mice (47.2 +/- 1.8 vs. 48.0 +/- 1.5 mg . kg-1 . min-1 in Cc1+/+ mice; P > 0.05), suggesting intact insulin action at this age. Consistently, the suppressive effect of insulin on hepatic glucose production (HGP) is intact (97.3 +/- 1.7 vs. 97.4 +/- 1.3% in Cc1+/+ mice; P > 0.05), and insulin-stimulated glucose uptake in white adipose tissue is elevated by approximatelytwofold in these mice (28.0 +/- 4.0 vs. 14.0 +/- 3.0 nmol . g-1 . min-1 in Cc1+/+ mice; P < 0.05).
###end p 52
###begin p 53
###xml 25 28 25 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 28 31 28 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 100 101 100 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 94 101 94 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 135 142 135 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 158 161 158 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 161 164 161 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 292 293 280 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 286 293 274 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>D</italic></xref>
###xml 368 371 352 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 371 374 355 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 381 382 365 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 399 400 383 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 393 400 377 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>E</italic></xref>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 165 169 <span type="species:ncbi:10090">mice</span>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
In contrast, 6-month-old Cc1-/- mice exhibit reduction in steady-state glucose infusion rate (Fig. 2A), suggesting insulin resistance (Table 2). At this age, Cc1-/- mice exhibit a marked hepatic insulin resistance, as reflected by an approximately14-fold increase in HGP during clamps (Fig. 2D) and reduced ability to suppress HGP (23.4 +/- 10.2 vs. 79.6 +/- 12.6% in Cc1+/+ mice; P < 0.005) (Fig. 2E).
###end p 53
###begin p 54
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 156 161 156 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pepck</italic>
###xml 181 182 181 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 175 182 175 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 253 257 253 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pdk4</italic>
###xml 292 297 292 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pepck</italic>
###xml 317 318 317 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 311 318 311 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 411 414 411 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 414 417 414 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 510 514 510 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cpt1</italic>
###xml 621 623 621 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 661 664 661 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 664 667 664 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 812 815 807 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 815 818 810 813 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 825 826 820 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 842 843 837 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 836 843 831 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 881 887 876 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G6Pase</italic>
###xml 907 908 902 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 901 908 896 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 970 973 965 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 973 976 968 971 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1024 1026 1015 1017 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 1032 1034 1023 1025 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 1038 1041 1029 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 1041 1044 1032 1035 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1051 1052 1042 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 418 422 <span type="species:ncbi:10090">mice</span>
###xml 668 672 <span type="species:ncbi:10090">mice</span>
###xml 819 823 <span type="species:ncbi:10090">mice</span>
###xml 977 982 <span type="species:ncbi:10090">mouse</span>
###xml 1045 1049 <span type="species:ncbi:10090">mice</span>
Insulin suppresses HGP by inhibiting gluconeogenesis and stimulating net hepatic glucose uptake and subsequent glycogen synthesis (21). Increase in fasting Pepck mRNA levels (Fig. 3A, i) suggests increased gluconeogenesis, and elevation in postprandial Pdk4 with normal, rather than reduced, Pepck mRNA levels (Fig. 3A, ii) suggests that the suppressive effect of insulin on gluconeogenesis is reduced in older Cc1-/- mice. Together with increased fatty acid oxidation at the fed state, as suggested by higher Cpt1 mRNA levels, and given that FFAs play a significant role in hepatic autoregulation of glucose production (22), the data suggest that the liver of Cc1-/- mice is geared toward gluconeogenesis, as manifested by higher levels of fed G6P content (0.31 +/- 0.03 vs. 0.17 +/- 0.05 mumol/g wet tissue in Cc1+/+ mice; P < 0.05) (Fig. 3B) rather than glucose, due to reduced G6Pase mRNA levels (Fig. 3A, ii). This could in part underlie the lower basal HGP in the Cc1-/- mouse (84.6 +/- 4.2 vs. 119.3 +/- 12.1 nmol . g-1 . min-1 in Cc1+/+ mice; P < 0.05).
###end p 54
###begin p 55
###xml 52 55 52 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 55 58 55 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 71 72 71 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 65 72 65 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 123 124 123 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 140 141 140 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 134 141 134 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>G</italic></xref>
###xml 255 266 255 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">glucokinase</italic>
###xml 287 288 287 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 281 288 281 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 432 435 432 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 435 438 435 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 553 556 549 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 556 559 552 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 566 567 562 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
###xml 560 564 <span type="species:ncbi:10090">mice</span>
Whole-body glycogen synthesis is decreased in adult Cc1-/- mice (Fig. 2B). With glycogen synthesis in muscle being normal (P > 0.05) (Fig. 2G), this suggests that the decrease in glycogen synthesis is primarily hepatic. With the mRNA level of fed hepatic glucokinase being intact (Fig. 3A, ii), it is possible that the increase in G6P content exerts a negative feedback effect on glucokinase activity to limit glycogen synthesis in Cc1-/- mice because glycogen energy store is not diminished (4.34 +/- 0.61 vs. 2.79 +/- 0.56 mg glycogen/g wet tissue in Cc1+/+ mice; P > 0.05). Although this hypothesis needs to be tested, it supports the notion that increase in G6P content mostly derives from reduced suppressive effect of insulin on gluconeogenesis.
###end p 55
###begin p 56
###xml 63 66 63 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 66 69 66 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 76 77 76 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 93 94 93 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 87 94 87 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 150 151 150 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 144 151 144 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>F</italic></xref>
###xml 200 201 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 288 289 288 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 305 306 305 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 299 306 299 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>H</italic></xref>
###xml 505 508 505 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 508 511 508 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 519 520 519 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 513 520 513 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>D</italic></xref>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
Insulin-stimulated whole-body glucose turnover is unaltered in Cc1-/- mice (P > 0.05) (Fig. 2C). This is consistent with normal glucose uptake (Fig. 2F) and glycolysis (not shown) in skeletal muscle (P > 0.05) and with an insignificant decrease in glucose uptake in white adipose tissue (P > 0.05) (Fig. 2H). Preservation of peripheral insulin sensitivity could compensate for elevation in gluconeogenesis and hepatic insulin resistance and contribute, with decreased G6Pase levels, to lower basal HGP in Cc1-/- (Fig. 2D).
###end p 56
###begin title 57
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 44 47 44 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Altered lipid metabolism in older inbred Cc1-/- mice.
###end title 57
###begin p 58
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 100 108 100 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srebp-1c</italic>
###xml 121 122 121 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 115 122 115 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 159 160 159 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 153 160 153 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 194 197 194 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 197 200 197 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 254 257 254 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 257 260 257 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 446 453 434 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 694 701 682 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
###xml 440 444 <span type="species:ncbi:10090">mice</span>
As expected from the positive transcriptional effect of hyperinsulinemia on lipogenic enzymes (23), Srebp-1c mRNA (Fig. 3A, ii) and FAS protein content (Fig. 4A) are elevated in fed 6-month-old Cc1-/- mice. This suggests increased de novo lipogenesis in Cc1-/- mice, as we have previously shown (24). Moreover, fasting serum FFA levels are significantly elevated (approximately1.5-fold) in parallel to increased visceral adiposity in these mice (Table 1). This suggests increased FFA mobilization out of the adipose tissue and transport into liver, where FFAs are partitioned into the triglyceride synthetic pathways to contribute to increased triglyceride levels beginning at 2 months of age (Table 1).
###end p 58
###begin p 59
###xml 135 136 135 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 129 136 129 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 197 204 197 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 351 352 351 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 345 352 345 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>C</italic></xref>
###xml 437 438 437 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 431 438 431 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>D</italic></xref>
###xml 479 486 479 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
Increased hepatic triglyceride content drives increased output, as assessed by elevation in serum ApoB48/ApoB100 protein levels (Fig. 4B). With steady-state serum triglyceride levels being normal (Table 1), it is likely that triglyceride is redistributed to the white adipose tissue, as suggested by elevation in FATP-1 and FAS protein content (Fig. 4C), rather than to skeletal muscle, in which FATP-1 protein levels are reduced (Fig. 4D) and triglyceride content is unaltered (Table 1).
###end p 59
###begin title 60
###xml 56 59 53 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 59 62 56 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
Normal pancreatic beta-cell function and area in inbred Cc1-/- mice.
###end title 60
###begin p 61
###xml 115 116 112 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 109 116 106 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 211 212 201 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 205 212 195 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 260 267 250 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ceacam1</italic>
###xml 396 397 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 390 397 362 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 558 561 530 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 561 564 533 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 571 572 543 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 588 589 560 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 582 589 554 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 663 666 631 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 666 669 634 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 676 677 644 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 749 752 713 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 752 755 716 719 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 762 763 726 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 836 839 797 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 839 842 800 803 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 935 936 892 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 929 936 886 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>C</italic></xref>
###xml 1034 1037 983 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 1037 1040 986 989 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
###xml 160 166 <span type="species:ncbi:10090">murine</span>
###xml 334 339 <span type="species:ncbi:10090">mouse</span>
###xml 565 569 <span type="species:ncbi:10090">mice</span>
###xml 670 674 <span type="species:ncbi:10090">mice</span>
###xml 756 760 <span type="species:ncbi:10090">mice</span>
###xml 843 847 <span type="species:ncbi:10090">mice</span>
###xml 1041 1045 <span type="species:ncbi:10090">mice</span>
Western blot analysis reveals that CEACAM1 is highly expressed in FACS-purified mouse pancreatic beta-cells (Fig. 5A, i). Consistently, CEACAM1 is expressed in murine beta-Min6 but not in alpha-TC6 cells (Fig. 5A, i). Quantitative RT-PCR analysis reveals that Ceacam1 mRNA is expressed at a ratio of approximately2:1 in FACS-purified mouse pancreatic beta-cells relative to non-beta-cells (Fig. 5A, ii). Acute-phase insulin secretion in response to glucose remains intact even at 10 months of age, with the area under the curve being comparable with that in Cc1+/+ mice (P > 0.05) (Fig. 5B), at which point, both insulin (0.53 +/- 0.06 vs. 0.26 +/- 0.01 ng/ml in Cc1+/+ mice; P < 0.05) and C-peptide levels (2.73 +/- 0.74 vs. 0.39 +/- 0.06 ng/ml in Cc1+/+ mice; P < 0.05) are elevated. Moreover, beta-cell area is intact in 6-month-old Cc1-/- mice, as assessed by immunohistochemical analysis with alpha-insulin antibody (blue) (Fig. 5C). Similarly, immunostaining with alpha-glucagon (red) reveals normal alpha-cell area relative to Cc1+/+ mice. Taken together, the data suggest that Ceacam1 deletion does not adversely affect beta-cell area or secretory function.
###end p 61
###begin title 62
###xml 47 50 47 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 50 53 50 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
Earlier onset of insulin resistance in outbred Cc1-/- mice.
###end title 62
###begin p 63
###xml 32 35 32 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 35 38 35 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 199 206 199 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t3">Table 3</xref>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
Similar to inbred mice, outbred Cc1-/- mice on mixed C57BL/6x129sv background exhibit an increase in body weight and visceral obesity compared with their wild-type counterparts at all ages examined (Table 3).
###end p 63
###begin p 64
###xml 8 11 8 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 11 14 11 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 163 170 139 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t3">Table 3</xref>
###xml 280 283 256 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 283 286 259 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 351 352 327 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 345 352 321 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>A</italic></xref>
###xml 475 482 451 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t3">Table 3</xref>
###xml 515 516 491 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 509 516 485 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>B</italic></xref>
###xml 575 578 547 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 578 581 550 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 619 620 591 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 697 698 669 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 691 698 663 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>A</italic></xref>
###xml 724 727 696 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 727 730 699 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 735 738 707 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 738 741 710 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 924 928 893 894 <sub xmlns:xlink="http://www.w3.org/1999/xlink">&#946;</sub>
###xml 1024 1028 986 987 <sub xmlns:xlink="http://www.w3.org/1999/xlink">&#946;</sub>
###xml 1077 1080 1036 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 1080 1083 1039 1042 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1098 1101 1057 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 1101 1104 1060 1063 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1117 1118 1076 1077 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1111 1118 1070 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>C</italic></xref>
###xml 1129 1132 1088 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 1132 1135 1091 1094 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1238 1245 1197 1204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t3">Table 3</xref>
###xml 1294 1297 1253 1256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 1297 1300 1256 1259 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
###xml 287 291 <span type="species:ncbi:10090">mice</span>
###xml 582 586 <span type="species:ncbi:10090">mice</span>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
###xml 1105 1109 <span type="species:ncbi:10090">mice</span>
###xml 1136 1140 <span type="species:ncbi:10090">mice</span>
###xml 1301 1305 <span type="species:ncbi:10090">mice</span>
###xml 1423 1427 <span type="species:ncbi:10090">mice</span>
Outbred Cc1-/- mice exhibit hyperinsulinemia (approximately3- to 4.3-fold) and a approximately1.5-fold decrease in insulin clearance beginning at 2 months of age (Table 3). Consistently, glucose level remains suppressed for 3 h after insulin injection in these mice as opposed to Cc1+/+ mice, in which glucose levels return to basal within 2 h (Fig. 6A). Impaired insulin clearance yields insulin resistance starting at 2 months of age, as indicated by random hyperglycemia (Table 3) and glucose intolerance (Fig. 6B; with blood glucose of 387 +/- 92 vs. 185 +/- 18 mg/dl in Cc1+/+ mice at 2 h after glucose injection; P < 0.0001). Because glucose levels decrease to a similar extent in 2- (Fig. 6A) and 6-month-old outbred Cc1-/- and Cc1+/+ mice after insulin injection (not shown), insulin response in peripheral tissues appears to be normal. Western blot analysis of immunopellets of the insulin receptor beta-subunit (IRbeta) using phosphotyrosine antibody (alpha-pTyr), reveals decreased ability of insulin to induce IRbeta phosphorylation in liver lysates of 2-month-old Cc1-/- compared with Cc1+/+ mice (Fig. 6C). Outbred Cc1-/- mice also exhibit elevation in fasting serum FFA and triglyceride levels starting at 2 months of age (Table 3). Taken together, the data suggest that outbred Cc1-/- mice develop altered lipid metabolism and insulin resistance, primarily in liver, with a more rapid onset than the inbred mice.
###end p 64
###begin p 65
###xml 81 84 69 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 84 87 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 94 101 82 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t3">Table 3</xref>
###xml 377 380 365 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 380 383 368 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 396 397 384 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 390 397 378 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>D</italic></xref>
###xml 502 505 486 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 505 508 489 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 515 516 499 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 384 388 <span type="species:ncbi:10090">mice</span>
###xml 453 457 <span type="species:ncbi:10090">mice</span>
###xml 509 513 <span type="species:ncbi:10090">mice</span>
Serum C-peptide levels are mildly elevated (by approximately1.5-fold) in outbred Cc1-/- mice (Table 3), suggesting compensatory increase in insulin secretion. Acute-phase insulin secretion in response to glucose is intact (not shown), and insulin secretion in response to increasing glucose levels and 20 mmol/l KCl is normal in primary islets derived from 6-month-old outbred Cc1-/- mice (Fig. 6D). Fasting serum glucagon level is also normal in these mice (40.19 +/- 0.89 vs. 42.36 +/- 1.99 pg/ml in Cc1+/+ mice; P > 0.05). This suggests that Ceacam1 deletion does not affect insulin secretion when propagated on the mixed C57BL/6x129sv background.
###end p 65
###begin title 66
DISCUSSION
###end title 66
###begin p 67
###xml 0 1 0 1 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 168 169 168 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 224 227 224 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 227 230 227 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 781 783 781 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 784 786 784 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
###xml 8 23 <span type="species:ncbi:10090">transgenic mice</span>
###xml 231 236 <span type="species:ncbi:10090">mouse</span>
l-SACC1 transgenic mice with liver inactivation of CEACAM1 demonstrated that CEACAM1 promotes insulin action by coordinated regulation of insulin and lipid metabolism (8,10,24). The purpose of this study was to use the null Cc1-/- mouse to reevaluate the role of CEACAM1 in insulin action in the absence of the potential confounding effect of the dominant-negative transgene. We herein report that homozygosity for a null Cc1 allele phenocopies transgenic inactivation of CEACAM1 in liver and causes visceral obesity together with impairment of insulin clearance and hyperinsulinemia, followed by insulin resistance, with an earlier onset when propagated on a mixed C57BL/6x129sv relative to pure C57BL/6 background (as with null mutation of the insulin receptor substrate 2 gene [25,26]). Despite abundant expression in beta-cells, null mutation of Ceacam1 does not reduce beta-cell secretory function or beta-cell area in response to glucose. This supports a key role for CEACAM1 in promoting hepatic insulin clearance.
###end p 67
###begin p 68
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 580 588 580 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srebp-1c</italic>
###xml 725 728 725 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 728 731 728 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 937 943 937 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G6Pase</italic>
###xml 545 549 <span type="species:ncbi:10090">mice</span>
###xml 732 736 <span type="species:ncbi:10090">mice</span>
###xml 754 758 <span type="species:ncbi:10090">mice</span>
Like its liver-specific inactivation, null mutation of Ceacam1 impairs insulin clearance and causes hyperinsulinemia and hepatic insulin resistance in association with increased steatosis. These findings are consistent with the high expression of CEACAM1 in liver (27), a major site for insulin clearance. We have shown that CEACAM1-dependent pathways mediate a decrease in FAS activity to protect the liver from the lipogenic effect of high insulin levels in portal vein and that this effect is abolished in the hyperinsulinemic Ceacam1 mutant mice (24). Together with increased Srebp-1c mRNA and FAS protein levels, this leads to increased de novo lipogenesis and contributes to increase in hepatic triglyceride content in Cc1-/- mice. Moreover, these mice exhibit a reduction in the suppressive effect of insulin on lipid oxidation and gluconeogenesis, which is manifested by increased G6P content, which, in association with reduced G6Pase mRNA level (and presumably activity), is partitioned to the triglyceride synthetic pathways. The data suggest that null mutation of Ceacam1 chronically gears the liver toward steatosis by increasing hepatic FFA supply and de novo lipogenesis in addition to increasing G6P production and its partitioning toward triglyceride synthesis.
###end p 68
###begin p 69
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r28">28</xref>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r31">31</xref>
###xml 183 186 183 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 186 189 186 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r32">32</xref>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r33">33</xref>
###xml 643 646 643 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 646 649 646 649 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1011 1016 1011 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ob/Ob</italic>
###xml 1018 1020 1018 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r32">32</xref>
###xml 1050 1052 1050 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r33">33</xref>
###xml 1361 1362 1361 1362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 1453 1455 1453 1455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r34">34</xref>
###xml 1798 1800 1798 1800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r35">35</xref>
###xml 1926 1929 1926 1929 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 1929 1932 1929 1932 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 112 118 <span type="species:ncbi:9606">humans</span>
###xml 190 194 <span type="species:ncbi:10090">mice</span>
###xml 650 654 <span type="species:ncbi:10090">mice</span>
###xml 1044 1048 <span type="species:ncbi:10090">mice</span>
###xml 1792 1796 <span type="species:ncbi:10090">mice</span>
###xml 1816 1821 <span type="species:ncbi:10090">mouse</span>
###xml 1933 1938 <span type="species:ncbi:10090">mouse</span>
Consistent with a positive correlation between liver steatosis, hyperinsulinemia, and high serum ApoB levels in humans and rodents (23,28-31), serum ApoB100/48 levels are elevated in Cc1-/- mice, suggesting increased triglyceride output. Normal circulating triglyceride levels support redistribution into peripheral tissues in response to compensatory increase in insulin secretion. As in leptin deficiency (32) and transgenic lipoatrophic AZIP mutation (33), propagation of Ceacam1 deletion on the C57BL/6 genetic background favors substrate redistribution to the adipose tissue rather than muscle. Although this leads to visceral obesity in Cc1-/- mice, it does not adversely affect insulin action in the periphery, in particular in muscle, where fatty acid uptake is reduced and triglyceride content is normal. Selective increase in triglyceride accumulation and alteration of insulin action in liver as opposed to muscle appears to be common in the C57BL/6 strain, as has been suggested by the phenotype of Ob/Ob (32) and lipoatrophic AZIP mice (33), which when propagated onto the FVB background exhibit triglyceride partitioning from liver to muscle. Likewise, transgenic inactivation of CEACAM1 in liver causes insulin resistance and fat accumulation in muscle and adipose tissue, in addition to liver, when propagated on a C57BL/6xFVB mixed background (8). In light of the modulation of the diabetes phenotype by strain-related genetic factors (34), it is possible that Ceacam1-null mutation would cause insulin resistance in muscle if propagated on the FVB genetic background. Conditional null mutation of the insulin receptor in liver yields hepatic insulin resistance with elevated lipogenesis and serum ApoB100/48 but with reduced serum triglycerides in comparison with wild-type mice (35). Whereas this mouse emphasizes the impact of interrupted insulin signaling at the receptor level on steatosis in liver, the Cc1-/- mouse phenotype highlights the critical role of CEACAM1 in regulating insulin action by coordinating insulin and lipid metabolism in liver and subsequently in extrahepatic tissues. This in vivo demonstration of a distinct CEACAM1-dependent postreceptor signaling pathway modulating insulin action by promoting insulin clearance provides proof of principle that hyperinsulinemia and hepatic steatosis can be a primary cause of insulin resistance, rather than a marker thereof.
###end p 69
###begin p 70
###xml 274 276 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 496 498 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r36">36</xref>
###xml 604 607 589 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 607 610 592 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 611 616 <span type="species:ncbi:10090">mouse</span>
Null mutation of Ceacam1 alters neither the insulin secretory function of beta-cells in response to glucose nor beta-cell area. Because beta-cell-specific null mutation of insulin receptor (betaIRKO) causes reduction in acute-phase insulin secretion in response to glucose (18), our finding suggests that CEACAM1 does not modulate the insulin signaling pathways mediating insulin secretion. It remains possible that deletion of Ceacam1 is compensated for by Ceacam2, a close relative of Ceacam1 (36), whose expression, albeit lower than that of Ceacam1 in beta-cells, is not significantly altered in the Cc1-/- mouse (not shown).
###end p 70
###begin p 71
###xml 70 73 70 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
Taken together, the data suggest that the primary metabolic effect of Cc1 deficiency is impaired insulin clearance rather than increased insulin secretion. The underlying mechanism of insulin resistance induced by hyperinsulinemia is a manifestation of several metabolic and cellular abnormalities, including increased lipogenesis in liver. This paradigm assigns a primary role for CEACAM1 in regulating insulin action by promoting insulin clearance and regulating lipogenesis in liver.
###end p 71
###begin p 72
R.N.K. has received National Institutes of Health Grant DK-67536. J.K.K. has received grants from the American Diabetes Association and the Pennsylvania State Department of Health. S.M.N. has received National Institutes of Health Grant DK-54254, a grant from the American Diabetes Association, and U.S. Department of Agriculture Grant USDA 38903-02315.
###end p 72
###begin p 73
###xml 83 87 <span type="species:ncbi:10090">mice</span>
We thank Dr. N. Beauchemin (McGill University, Montreal, Canada) for providing the mice. We also thank Drs. Jill Schroeder-Gloeckler and Qusai Y. Al-Share and Mats Fernstrom for technical assistance and scientific discussions.
###end p 73
###begin title 74
REFERENCES
###end title 74
###begin p 75
###xml 158 161 158 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 161 164 161 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 173 176 173 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 192 195 192 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 195 198 195 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 312 313 312 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 366 368 362 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">*P</italic>
###xml 380 383 376 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 383 386 379 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
Insulin tolerance test in inbred mice. Glucose levels were measured in venous blood extracted from overnight-fasted 2- and 6-month-old age-matched wild-type (Cc1+/+, o) and Cc1 knockout mice (Cc1-/-, *) following an intraperitoneal injection with insulin (0.125 unit/kg) for 0-5 h. Experiments were performed on n >/= 10 per group. Values expressed as means +/- SE. *P < 0.05 vs. Cc1+/+.
###end p 75
###begin p 76
###xml 112 115 112 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 115 118 115 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 132 135 127 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 135 138 130 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 175 176 144 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 229 230 196 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 294 295 261 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 347 348 314 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 398 399 365 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 457 458 424 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 543 544 510 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 616 617 583 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 655 656 622 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 746 748 713 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 754 756 721 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 789 791 754 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">*P</italic>
###xml 803 806 768 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 806 809 771 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
Insulin response during hyperinsulinemic-euglycemic clamps in awake inbred mice. Five- to 6-month-old wild-type Cc1+/+ (square) and Cc1-/- mice (blacksquare, square, filled) (n >/= 10 per group) were subjected to clamp analysis. A: Steady-state glucose infusion rates during euglycemic clamps. B: Insulin-stimulated whole-body glycogen synthesis. C: Insulin-stimulated whole-body glucose turnover. D: HGP during basal and insulin-stimulated (clamp) states. E: Hepatic insulin action represented as insulin-mediated percent suppression of HGP. F: Insulin-stimulated glucose uptake in skeletal muscle (gastrocnemius). G: Skeletal muscle glycogen synthesis. H: Insulin-stimulated glucose uptake in white adipose tissue (WAT). Values (all in nmol . g-1 . min-1) are expressed as means +/- SE. *P < 0.05 vs. Cc1+/+.
###end p 76
###begin p 77
###xml 125 128 125 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 128 131 128 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 145 148 140 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 148 151 143 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 188 189 157 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 257 258 224 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 301 302 268 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 459 461 421 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">*P</italic>
###xml 473 476 435 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 476 479 438 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
Northern blot analysis and quantitation of glucose intermediates in livers of inbred mice. Livers from 6-month-old wild-type Cc1+/+ (square) and Cc1-/- mice (blacksquare, square, filled) (n >/= 7 per group) were isolated for mRNA analysis by Northern blot (A) and determination of hepatic G6P levels (B). Representative Northern gels from analysis of mRNA levels at fasting and fed states are shown normalized to beta-actin. Values expressed as means +/- SE. *P < 0.05 vs. Cc1+/+.
###end p 77
###begin p 78
###xml 89 90 89 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 92 93 92 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 99 100 99 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 139 142 139 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 142 145 142 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 152 153 152 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 401 402 383 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 146 150 <span type="species:ncbi:10090">mice</span>
###xml 607 611 <span type="species:ncbi:10090">mice</span>
Western blot analysis of proteins involved in lipid homeostasis in inbred mice. Tissues (A, C, and D) were removed from 6-month-old inbred Cc1-/- mice (n >/= 5 per group), and lysates were analyzed by 7% SDS-PAGE and sequential immunoblotting with alpha-FAS and alpha-FATP-1 antibodies followed by reprobing with alpha-tubulin or alpha-actin antibodies to account for the amount of proteins analyzed. B: Serum was diluted and analyzed by 4-10% gradient SDS-PAGE and immunoblotting with an antibody against apolipoprotein (apo)B, which recognizes both apoB48 and apoB100. A representative gel of five to six mice per group is included.
###end p 78
###begin p 79
###xml 63 64 60 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 66 67 63 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 261 263 245 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ii</italic>
###xml 468 469 443 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 610 613 585 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 613 616 588 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 625 628 600 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 628 631 603 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 672 673 647 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 729 731 700 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">*P</italic>
###xml 743 746 714 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 746 749 717 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 751 752 722 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 813 816 784 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 816 819 787 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 824 827 795 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 827 830 798 801 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1019 1022 987 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 1022 1025 990 993 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1038 1041 1006 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 1041 1044 1009 1012 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 246 251 <span type="species:ncbi:10090">mouse</span>
###xml 370 375 <span type="species:ncbi:10090">mouse</span>
###xml 632 636 <span type="species:ncbi:10090">mice</span>
###xml 831 835 <span type="species:ncbi:10090">mice</span>
###xml 1045 1049 <span type="species:ncbi:10090">mice</span>
The effect of Ceacam1 on insulin secretion and beta-cell area. A: i, CEACAM1 protein content in immortalized beta-cell islets from betaIRKO mice and in alpha-TC6 and beta-Min6 cells was analyzed by Western blot analysis using an antibody against mouse CEACAM1. ii, Ceacam1 mRNA levels were determined in FACS-purified beta-cells and non-beta-cells derived from a normal mouse by real-time PCR analysis. Data are normalized for beta-actin and expressed as fold change. B: Insulin levels in response to glucose were measured for 0-30 min after intraperitoneal injection of age-matched 6- and 10-month-old inbred Cc1+/+ (o) and Cc1-/- mice (*). Experiments were performed on n >/= 7 per group. Values are expressed as means +/- SE. *P < 0.05 vs. Cc1+/+. C: Pancreas sections from four each of the 6-month-old inbred Cc1+/+ and Cc1-/- mice were fixed and immunostained with antibodies against insulin (blue), glucagon (red), and somatostatin (green). beta-Cell area was estimated by morphometric analysis of 44 islets from Cc1+/+ and 33 from Cc1-/- mice. Values expressed as means +/- SE in arbitrary units (AU) are presented in the graph. Magnification x20. (Please see  for a high-quality digital representation of this figure.)
###end p 79
###begin p 80
###xml 50 51 50 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 187 190 187 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 190 193 190 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 202 205 202 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 205 208 205 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 314 315 314 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 371 373 367 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">*P</italic>
###xml 385 388 381 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 388 391 384 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 393 394 389 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 491 494 487 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 494 497 490 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 506 509 502 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 509 512 505 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 668 670 662 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">*P</italic>
###xml 682 685 676 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 685 688 679 682 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 690 691 684 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 793 796 787 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 796 799 790 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 804 807 798 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 807 810 801 804 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 885 889 879 880 <sub xmlns:xlink="http://www.w3.org/1999/xlink">&#946;</sub>
###xml 1089 1090 1076 1077 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 1137 1141 1120 1121 <sub xmlns:xlink="http://www.w3.org/1999/xlink">&#946;</sub>
###xml 1219 1221 1199 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ii</italic>
###xml 1333 1334 1313 1314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1384 1387 1364 1367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 1387 1390 1367 1370 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1404 1407 1379 1382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 1407 1410 1382 1385 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1447 1448 1396 1397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 513 517 <span type="species:ncbi:10090">mice</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
###xml 600 604 <span type="species:ncbi:10090">mice</span>
###xml 1016 1027 <span type="species:ncbi:3704">horseradish</span>
###xml 1303 1307 <span type="species:ncbi:10090">mice</span>
###xml 1411 1415 <span type="species:ncbi:10090">mice</span>
Insulin resistance in outbred C57BL/6x129sv mice. A: For insulin tolerance, glucose levels were measured in venous blood extracted from overnight-fasted 6-month-old age-matched wild-type Cc1+/+ (o) and Cc1-/- mice (*) injected intraperitoneally with 0.125 units/kg insulin for 0-3 h. Experiments were performed on n >/= 9 per group. Values are expressed as means +/- SE. *P < 0.05 vs. Cc1+/+. B: For glucose tolerance test, blood glucose level was determined in overnight-fasted 2-month-old Cc1+/+ (o) and Cc1-/- mice (*) mice at 0-120 min after intraperitoneal glucose injection (2 g/kg). Six to 11 mice were used in each group. Values are expressed as means +/- SE. *P < 0.05 vs. Cc1+/+. C: For Western blot analysis of insulin receptor phosphorylation, liver lysates of 2-month-old outbred Cc1-/- and Cc1+/+ controls were incubated with (+) or without (-) 100 nmol/l insulin. The IRbeta was immunoprecipitated (Ip), analyzed by 7% SDS-PAGE, and transferred to nitrocellulose membrane for immunoblotting (Ib) with horseradish peroxidase-conjugated phosphotyrosine (alpha-pTyr) antibody (i). Membranes were reprobed (reIb) with alpha-IRbeta antibody to account for the amount of insulin receptor in the immunopellets (ii). The gel is representative of three different experiments each performed on two mice per treatment per group. D: Islets were isolated from 6-month-old wild-type Cc1+/+ (square) and Cc1-/- mice (blacksquare, square, filled) (n > 3 per group) by collagenase digestion followed by centrifugation over histopaque gradient. Recovered islets were cultured overnight in RPMI containing 5.5 nmol/l glucose. Insulin secretion was assayed by incubating 10 islets in Kreb's buffer containing different concentrations of glucose or 20 mmol/l KCl for 1 h. Amount of insulin secreted was normalized with DNA content, and values are expressed as means +/- SE.
###end p 80
###begin p 81
###xml 39 43 <span type="species:ncbi:10090">mice</span>
Metabolic parameters of inbred C57BL/6 mice
###end p 81
###begin p 82
Data are means +/- SE.
###end p 82
###begin p 83
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 9 12 9 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 12 15 12 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 20 23 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 23 26 23 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
P < 0.05 Cc1-/- vs. Cc1+/+ control mice.
###end p 83
###begin p 84
###xml 139 143 <span type="species:ncbi:10090">mice</span>
Metabolic parameters at basal state (overnight fasted) and during a 2-h hyperinsulinemic-euglycemic clamp experiment in 6-month-old inbred mice
###end p 84
###begin p 85
Data are means +/- SE.
###end p 85
###begin p 86
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 13 16 13 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 16 19 16 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 38 39 38 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
P < 0.05 vs. Cc1+/+ mice by Student's t test.
###end p 86
###begin p 87
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Metabolic parameters of outbred B6x129sv mice
###end p 87
###begin p 88
Data are means +/- SE.
###end p 88
###begin p 89
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 12 15 12 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 20 23 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cc1</italic>
###xml 23 26 23 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
P < 0.05 Cc1-/- vs. Cc1+/+ control mice.
###end p 89

